Placing the burden of bacteraemia in perspective

Clinical Microbiology and Infection

Volumn 19, Issue 6, 2013, Pages 489-491

  Schonheyder H C ^a   Paul, M ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL INFECTION; ANTIBIOTIC THERAPY; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; EDITORIAL; ELECTRONIC MEDICAL RECORD; EUROPE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INCIDENCE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORTALITY; PRIORITY JOURNAL; STANDARDIZATION; SURVIVOR;

BACTEREMIA; HUMANS;

EID: 84876804079     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12234     Document Type: Editorial

References (22)

1. Bulloch W. The history of bacteriology. New York: Dover Publications (first published 1938 by Oxford University Press), 1979.
2. Theodorides J. Casimir Davaine (1812-1882): a precursor of Pasteur. Med Hist 1966; 10: 155-165.
3. Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 2013; 19: 492-500.
4. Goto M, Al-Hasan MN. Overall burden of bacteraemia and nosocomial bacteraemia in North America and Europe. Clin Microbiol Infect 2013; 19: 501-509.
5. Leibovici L. Long-term consequences of severe infections. Clin Microbiol Infect 2013; 19: 510-512.
6. Mayer J, Greene T, Howell J et al. Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis 2012; 55: 364-370.
7. Kirn TJ, Weinstein MP. Update on blood cultures: how to obtain, process, report and interpret. Clin Microbiol Infect 2013; 19: 513-520.
8. Roberts FJ. Definition of polymicrobial bacteremia. Rev Infect Dis 1989; 11: 1029-1030.
9. Jensen US, Knudsen JD, Ostergaard C, Gradel KO, Frimodt-Moller N, Schonheyder HC. Recurrent bacteraemia: a 10-year regional population-based study of clinical and microbiological risk factors. J Infect 2010; 60: 191-199.
10. CDC/NHSN. Central Line-Associated Bloodstream Infection (CLABSI) Event, 2013. Available at http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf (last accessed 9 March 2013).
11. Gradel KO, Knudsen JD, Arpi M, Ostergaard C, Schonheyder HC, Sogaard M. Classification of positive blood cultures: computer algorithms versus physicians' assessment-development of tools for surveillance of bloodstream infection prognosis using population-based laboratory databases. BMC Med Res Methodol 2012; 12: 139.
12. Leal J, Gregson DB, Ross T, Flemons WW, Church DL, Laupland KB. Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol 2010; 31: 740-747.
13. Trick WE, Zagorski BM, Tokars JI et al. Computer algorithms to detect bloodstream infections. Emerg Infect Dis 2004; 10: 1612-1620.
14. Martin CM. A national bacteremia registry. J Infect Dis 1969; 120: 495-496.
15. Agency HP. Health Protection Report, Bactaermia, 2013. Available at http://www.hpa.org.uk/hpr/infections/bacteraemia.htm (last accessed 9 March 2013).
16. Skogberg K, Lyytikainen O, Ollgren J, Nuorti JP, Ruutu P. Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect 2012; 18: E170-E176.
17. MiBa. Den Danske Mikrobiologisdatabase, 2012. Available at http://miba.ssi.dk/Service/English.aspx (last accessed 9 March 2013).
18. Kariv G, Paul M, Shani V, Muchtar E, Leibovici L. Benchmarking inappropriate empirical antibiotic treatment. Clin Microbiol Infect 2012; doi: 10.1111/j.1469-0691.2012.03965.x. [Epub ahead of print].
19. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54: 4851-4863.
20. Bille E, Dauphin B, Leto J et al. MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect 2012; 18: 1117-1125.
21. Leibovici L, Paul M, Andreassen S. Balancing the benefits and costs of antibiotic drugs: the TREAT model. Clin Microbiol Infect 2010; 16: 1736-1739.
22. Paul M, Andreassen S, Tacconelli E et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother 2006; 58: 1238-1245.